Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Top Cited Papers
- 1 February 2010
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 375 (9716) , 735-742
- https://doi.org/10.1016/s0140-6736(09)61965-6
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Lipid lowering for primary preventionThe Lancet, 2009
- Effects of High-Dose Simvastatin Therapy on Glucose Metabolism and Ectopic Lipid Deposition in Nonobese Type 2 Diabetic PatientsDiabetes Care, 2009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trialThe Lancet, 2008
- Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysisPublished by Elsevier ,2008
- Rosuvastatin in Older Patients with Systolic Heart FailureNew England Journal of Medicine, 2007
- Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinicsThe alliance studyJournal of the American College of Cardiology, 2004
- Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinicsJournal of the American College of Cardiology, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)JAMA, 2002